NATHAN TYSON: Open Payments
NPI 1497536882 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 26 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $105 |
| ABBVIE INC. | 4 | $79 |
| Neurocrine BioSciences, Inc. | 2 | $76 |
| Janssen Pharmaceuticals, Inc | 2 | $62 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Tris Pharma Inc | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $24 |
| Almatica Pharma LLC | 1 | $23 |
Products named: AUSTEDO XR, CAPLYTA, VRAYLAR, INGREZZA, SPRAVATO, Auvelity, Dyanavel XR, FANAPT.
Industry payments across GA — which companies pay providers there.
